News
Bayer A.G. ( OTCPK:BAYZF) ( OTCPK:BAYRY) said that an advisory panel of the European Medicines Agency (EMA), endorsed the ...
9h
Pharmaceutical Technology on MSNBayer’s Eylea set for longer treatment intervals to challenge Roche’s VabysmoAn EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results